World Conference on
Cancer Science and Therapeutic Innovations
May 1 - 2 , 2025 | Bangkok, Thailand
About WCCSTI-Bangkok-2025
The World Conference on Cancer Science and Therapeutic Innovations (WCCSTI-Bangkok-2025), scheduled for May 1-2, 2025, in Bangkok, Thailand, will provide a global platform for leading oncologists, researchers, and healthcare professionals to share cutting-edge developments in cancer treatment. The event will highlight the latest advancements in cancer immunotherapy, precision medicine, and early detection technologies, fostering discussions aimed at transforming cancer care.
Attendees will explore a broad range of topics, including breakthroughs in personalized oncology, innovative drug delivery systems, AI-driven diagnostics, and emerging therapies such as CAR-T cell treatments and cancer vaccines. The conference will also focus on critical areas of research like cancer genomics, tumor microenvironments, and overcoming drug resistance, encouraging interdisciplinary collaboration to drive progress in the fight against cancer.
Held in the vibrant city of Bangkok, the conference offers a unique blend of professional enrichment and cultural experience. Participants will not only engage with leading experts in the field but also enjoy the opportunity to experience Thailand’s rich heritage, making this event a valuable occasion for advancing cancer science and therapeutic innovations on a global scale.
Publication Opportunity
Unlock Your Research's Potential
At our conference, we're not just about presentations; we're about making your research shine. Here's what you gain:
- Digital Object Identifier (DOI): Every accepted and registered abstract is assigned a unique Digital Object Identifier (DOI) by Crossref, ensuring the longevity, accessibility, and recognition of your research abstract. Our Crossref DOI Prefix is 10.62422, which precedes the unique identifier assigned to each abstract.
- Abstract Proceedings: Your research deserves recognition. That's why we publish the abstracts of all accepted and registered submissions in our esteemed Conference Abstract Proceedings. This prestigious publication ensures your work is not just seen but formally recognized and cited.
- ISBN Number: Recognizing the value of your research, we have assigned a dedicated ISBN number to our Conference Abstract Proceedings. This year, the digital format will feature the following: ISBN Online: 978-81-981590-6-9. This ISBN ensures your work is recognized and accessible for citation in digital academic realms.
By participating in our conference, you are not just presenting; you are positioning your work on a global stage where it will be recognized, cited, and valued by the academic community. With the addition of both DOI and ISBN, your research will achieve a level of visibility and credibility that enhances your academic standing.
Who Can Attend?
- Oncologists and cancer researchers
- Medical and surgical oncologists
- Radiation oncologists and radiologists
- Immunologists and molecular biologists
- Clinical trial coordinators and research scientists
- Geneticists and experts in cancer genomics
- Pharmacologists and pharmaceutical scientists
- Nurses and allied health professionals in oncology
- Public health professionals focused on cancer prevention and control
- Medical students and trainees interested in oncology
- Healthcare administrators and policymakers in cancer care
- Biotechnologists and innovators in cancer therapeutics
- Palliative care specialists and patient support coordinators
Why to Attend?
- Learn from experts in your field
- Expand your professional network
- Gain new perspectives and insights
- Present your own research and receive feedback
- Discover new career paths and job opportunities
- Expose yourself to new ideas and innovations
- Explore new cultures and countries
- Take a break from your routine and recharge
- Receive a certificate of participation
Conference Schedule
Our tentative program is scheduled as follows.